Skip to main content
Log in

Increased cytotoxicity of food-borne mycotoxins toward human cell lines in vitro via enhanced cytochrome p450 expression using the MTT bioassay

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Eight food-borne mycotoxins epidemiologically implicated in human disease were tested for their cytotoxic effects on human cells previously immortalised and transfected to introduce human cytochrome p450(CYP 450) genes. Such cells retain many characteristics of normal cell growth and differentiation while simultaneously having the potential of either increasing or decreasing the metabolic activity (cytotoxicity) of the challenging mycotoxins. The MTT assay provided an indication of cytotoxicity. Of the nine CYP 450s introduced CYP1A2 was most effective,rendering the cells 540 times more sensitive than the control cells to aflatoxin B1, 28 times more sensitive to aflatoxin G1 and 8-fold more sensitive to ochratoxin A. CYP3A4 resulted in the cells being 211 times more toxic to aflatoxin B1 and 8-fold more toxic to aflatoxin G1 while CYP 2A6, CYP 3A5 and CYP 2E1 also produced observable effects. No increase in metabolic activity was found using cyclopiazonic acid, deoxynivalenol,fumonisin B1, patulin or T-2 toxin. CD5Os were calculated for the mycotoxins against the non-CYP-introduced control cells. There was almost a five order of magnitude difference between the most toxic,T-2 toxin (CD50 0.0057 μg/ml) and the least toxic, fumonisin 1(CD50 476.2 μg/ml). In vitro biological assays thus provide an excellent system for quantifying the often low CD50s expressed bymycotoxins in foods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Steyn PS. Mycotoxins, general view, chemistry and structure. Toxicol Lett 1995; 82/83: 843–851.

    Article  PubMed  Google Scholar 

  2. Smith JE, Solomons GL, Lewis CW, Anderson JG. Mycotoxins in Human Nutrition and Health. Brussels, Belgium: XII, European Commission, 1994.

    Google Scholar 

  3. Chu FS. Mycotoxins: food contamination, mechanism, carcinogenic potential and preventive measures. Mutation Res 1991; 259: 291–306.

    Article  PubMed  Google Scholar 

  4. Pohland AE. Mycotoxins in review. Food Additives and Contaminants 1993; 10: 17–28.

    PubMed  Google Scholar 

  5. Ueno Y. Diet/toxin interactions. Food Additives and Contaminants 1993; 10: 145–156.

    PubMed  Google Scholar 

  6. Lewis CW, Anderson JG, Smith JE. Health-related aspects of the genus Aspergillus. In: Smith JE (ed), Aspergillus. New York, USA: Plenum Press, 1994; 219–261.

    Google Scholar 

  7. Fentem I, Balls M. In vitro alternatives to toxicity testing in animals. Chem Industry 1992; 6: 207–211. 102

    Google Scholar 

  8. Robb J, Norval M, Neill WA. The use of tissue culture for the detection of mycotoxins. Lett Appl Microbiol 1990; 10: 161–165.

    PubMed  Google Scholar 

  9. Dombrink-Kurtzman MA, Bennett GA, Richard JL. An optimised MTT bioassay for determination of fumonisins in turkey lymphocytes. Journal of AOAC International 1994; 77: 512–516.

    PubMed  Google Scholar 

  10. Visconti A, Minervini F, Lucivero G, Gambatesa V. Cytotoxic and immunotoxic effects of Fusarium mycotoxins using a rapid colorimetric bioassay. Mycopathologia 1991; 133: 181–85.

    Article  Google Scholar 

  11. Reddel RR, Ke Y, Gerwin BI, McMenanim MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with plasmid containing the SV40. Cancer Res 1988; 48:1904–1909.

    PubMed  Google Scholar 

  12. Macé K, Gonzalez FJ, McConnell JR, Garner RC, Aventi E, Harris C, Pfeifer AMA. Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2. Mol Carcinogenesis 1994; 11: 65–73.

    Google Scholar 

  13. Freshney RI (ed) Animal Cell Culture: A Practical Approach, 2nd edn. New York, USA: Oxford University Press, 1992.

    Google Scholar 

  14. Fink-Gremmels J, Jahn A, Blom MJ. Toxicity and metabolism of ochratoxin A. Natural Toxins 1995; 3: 214–220.

    PubMed  Google Scholar 

  15. Ueno Y, Umemori K, Niimi E, Tanumaga S, Sugamata M, Ihara T, Sekijima M, Kawai K, Ueno I, Tashiro F. Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukaemia cells. Natural Toxins 1995; 3: 129–137.

    PubMed  Google Scholar 

  16. Lemieux P, Michaud M, Page M. A new formazan amplified clonogenic assay for cytoxicity testing. Biotechnology Techniques 1993: 7; 597–602.

    Article  Google Scholar 

  17. Reubel GH, Gareis M, Amselgruber WM. Cytotoxicity evaluation of mycotoxins by an MTT bioassay. Mycotoxin Res 1987; 3: 85–96.

    Google Scholar 

  18. Kitabatake N, Doi E, Trivadi AB. Toxicity evaluation of the mycotoxins, citrinin and ochratoxin A, using several animal cell lines. Comp Biochem Physiol 1993; 105C: 429–433.

    Google Scholar 

  19. Crespi CL, Penman BW, Steimel DT, Gelboin HV, Gonzalez FJ. The development of a human cell line stably expressing human CYP 3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP 1A2 and CYP 2A3. Carcinogenesis 1991; 12: 355–359.

    PubMed  Google Scholar 

  20. Gallagher LC, Wienkers LC, Stapleton PL, Kunze KL, Eatson DL. Role of human microsomal and human complementing DNA-expressed cytochromes P450 1A2 and 3A4 in the bioactivation of aflatoxin B1. Cancer Res 1994; 54: 101–108.

    PubMed  Google Scholar 

  21. Kirby GM, Chemin W, Montesano R, Chisari FV, Lang MA, Wild CP. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis virus transgenic mice. Molecular Carcinogenisis 1994; 11: 74–80.

    Google Scholar 

  22. Nigam SK, Ghosh SK, Malaviya R. Aflatoxin, its metabolism and carcinogenesis - a historical review. Toxin Reviews 1994; 13: 179–203.

    Google Scholar 

  23. Hietanen E, Bartsch H, Béréziat JC, Castegnaro M, Michelon J. Characterization of the cytochrome P450 isoenzyme that metabolises ochratoxin A1, using metabolic inducers, inhibitors and antibodies. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds), Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours. Lyon, France: IARC, 1991: 297–304.

    Google Scholar 

  24. Omar RF, Rahimtula AD, Bartsch H. Role of cytochrome P-450 in ochratoxin A-stimulated lipid peroxidation. J Biochem Toxicol 1991; 6: 203–209.

    PubMed  Google Scholar 

  25. Gorski JG, Hall SD, Jones DR, VandenBranden M, Wrighton R. Regioselective biotransformation of midazolam by members of the human CYP3A subfamily. Biochem Pharmacol 1994; 47: 1643–1653.

    Article  PubMed  Google Scholar 

  26. Kolars JC, Lown KS, Schmeidlin-Ren P, Ghosh M, Fang C, Wrighton SA, Merion RM, Watkins PB. CYP3A gene expression in human gut epithelium. Pharmacogenetics 1994; 4: 247–258.

    PubMed  Google Scholar 

  27. Netter KJ. The role of nutrients in detoxification mechanisms. In: Kotsonis FM, Mackey M, Hjelle JJ (eds), Nutritional Toxicology. New York, USA: Raven Press, 1994; 1–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, C., Smith, J., Anderson, J. et al. Increased cytotoxicity of food-borne mycotoxins toward human cell lines in vitro via enhanced cytochrome p450 expression using the MTT bioassay. Mycopathologia 148, 97–102 (2000). https://doi.org/10.1023/A:1007130923558

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007130923558

Navigation